Fourier Health
Founded 2022 · 61 employees on LinkedIn · 6 known investors
Fourier Health builds infrastructure to unlock unstructured clinical data from healthcare systems, enabling AI models and clinicians to access actionable intelligence from records currently locked in PDFs and fragmented systems. The company serves healthcare providers, researchers, and AI developers seeking trustworthy clinical data integration and analysis.
Also known as Fourier
Founders & leadership
Fourier Health was founded in 2022 by Christopher Lee.

Investors · 6
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$8.4M disclosed across 1 of 3 rounds · 2025
- Undisclosed amountSeed FundingOct 2025Source ↗
- $8.4MSeedOct 2025 · 2 sources
Yosemite (lead), Innospark Ventures, NextGen Venture Partners, Tau Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Fourier Health is a healthcare technology company that automates the intake and structuring of inbound medical records. Its platform ingests unstructured and semi-structured clinical inputs — faxes, PDFs, scanned and handwritten documents, HL7 feeds, notes and voicemail — then parses, classifies, matches, de-duplicates and extracts clinical elements such as diagnoses, medications and labs, coding them against standards including ICD-10, SNOMED, LOINC and RxNorm. Outputs are reviewed by clinicians in the loop and delivered schema-aligned and cited back to source, so individual fields are traceable.
The product is organized into three lines. Fourier Intake automatically ingests, classifies, sorts, labels and uploads inbound records, which the company says reduces manual entry by 80%. Fourier Insights produces configurable, specialty-specific clinical deliverables — pre-visit status, patient and specialty summaries, decision support, care gaps and index files — embedded directly in the EHR; the company cites integrations with Epic, Cerner and Athena. Fourier Infrastructure delivers clinician-verified, de-identified, HIPAA-grade structured data via API and endpoints including FHIR, REST, CSV and S3, with custom feeds and exports. The platform is described as model-agnostic, positioned as a structuring and staging layer beneath customers' own AI models rather than a replacement for them. Additional described capabilities include querying Health Information Exchange consortiums to augment patient records and reduce manual chart chasing, and support for use cases such as patient intake, second-opinion summaries and pre-charting for annual wellness visits.
Founding story
Fourier Health was founded in late 2023 by Christopher Lee and James Lloyd, both repeat healthcare technology founders. Lee, who serves as CEO, holds a PhD from the Harvard-MIT Division of Health Sciences and Technology and previously co-founded and served as COO of InfiniteMD, an expert medical opinion platform with more than 3,500 specialty physicians that was acquired by Alight (via ConsumerMedical). Lloyd, the CTO, is a former Epic engineer who co-founded and was CTO of Redox, a healthcare interoperability platform reported as integrated with over 9,000 healthcare systems and 120 EHRs and backed by nearly $100 million in funding.
Business model
Fourier Health sells a B2B software platform to healthcare organizations, delivering structured clinical intelligence through EHR-embedded deliverables and API-based data feeds. Engagements center on integration with a customer's existing EHR and workflows, with a proprietary network of specialist clinicians reviewing and validating outputs.
Sources describe enterprise sales of the platform and its data feeds to health systems and other healthcare organizations, but do not specify pricing or contract structure. The company frames its value in customer economics such as reduced administrative time, additional fee-for-service revenue from intake summaries, and risk-adjustment capture.
Traction
Company-reported figures include more than 9 million pages of medical records processed, 19 million clinical annotator events captured, 10M+ labeled data points, an 83.9% reduction in records reviewed per patient, 82% clinician satisfaction, and an F1 score above 0.82. Press materials cite client-reported outcomes of over 98% reduction in document validation, two to three hours of administrative burden returned per patient, average document sorting turnaround under four minutes, a 5-10% increase in evaluation and management revenue opportunities, and 10-15% growth in physician capacity. A customer testimonial reports 52 minutes saved per patient. Third-party coverage listed the company at 2-10 employees as of October 2025.
Latest developments
The $8.4 million seed round was announced on October 17, 2025, with proceeds directed to R&D infrastructure and hiring across engineering, sales and implementation, and to deepening integrations with major EHR vendors and health systems. The company subsequently published product lines covering intake automation, EHR-embedded clinical deliverables and API-based structured data delivery, along with blog posts dated March and April 2026.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Fourier Health positions itself as clinical data infrastructure — a standardized, clinician-verified layer between healthcare records and any AI model — rather than an application-layer AI product, describing itself as the first AI platform built to fully automate medical record intake. Its founders' prior companies (Redox and InfiniteMD) are used to establish credibility in healthcare interoperability and specialist clinical networks.
Stated differentiators include a clinician-in-the-loop verification architecture with source citation and field-level traceability, model-agnostic design that sits beneath customers' AI roadmaps, native embedding in major EHRs, specialty-specific configurable deliverables, and the ability to enrich records from Health Information Exchanges.
Technology
The core technology is a structuring layer combining OCR and document parsing, classification and labeling, entity extraction and terminology mapping (ICD-10, SNOMED, LOINC, RxNorm), record matching and de-duplication, and HL7/FHIR interoperability. A clinician-in-the-loop review step validates outputs and supplies annotation data that is used for continued model improvement. The company reports an F1 score of 0.82+ on its structuring tasks, states it is model-agnostic across LLM vendors, and describes real-time structuring with delivery into EHRs and APIs. It also cites domain-specific AI for last-mile LLM enablement and specialty-specific customization.
Go-to-market
The company markets directly to healthcare enterprises through a demo-request motion on its website, supported by segment-specific positioning for health systems and academic medical centers, specialty networks and MSOs, and AI and research partners. Following its seed round it stated plans to build out sales and implementation teams alongside engineering, and to scale integrations with major EHR vendors and health systems.
Health systems and academic medical centers, specialty networks and management services organizations, and AI and research partners. Buyers referenced in customer testimonials include health system chief AI officers, technology and data leaders, and quality and clinical operations executives.
Geography
Headquartered in Miami, Florida, serving healthcare providers in the United States.
History
The company was founded in late 2023 and raised pre-seed capital from Lasagna, NextGen Venture Partners, Myelin and Despierta. On October 17, 2025 it announced an $8.4 million seed round led by Yosemite with participation from Innospark Ventures, NextGen Venture Partners and Tau Ventures, earmarked for R&D infrastructure and for building engineering, sales and implementation teams. By 2026 the website presented three product lines — Fourier Intake, Fourier Insights and Fourier Infrastructure — along with published usage metrics and health system customer testimonials.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 10
by search overlapCompanies competing with Fourier Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 1
launches, deals, and filingsFourier Health announced $8.4 million in seed funding led by Yosemite with participation from Innospark Ventures, NextGen Venture Partners and Tau Ventures, plus previously undisclosed pre-seed funding from Lasagna, NextGen Venture Partners, Myelin and Despierta. Proceeds are earmarked for R&D infrastructure and hiring in engineering, sales and implementation.
$8.4M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Fourier Healthfourierhealth.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Fourier Health do?
- Fourier Health is a clinician-in-the-loop AI platform that automates medical record intake and turns unstructured clinical data into structured summaries.
- Who founded Fourier Health?
- Fourier Health was founded by Christopher Lee in 2022.
- Who are Fourier Health's investors?
- Fourier Health's investors include NextGen Venture Partners, Tau Ventures, Innospark Ventures, Yosemite.
- How much funding has Fourier Health raised?
- Fourier Health has disclosed $8.4M raised across 1 of its 3 known rounds.









